Call for Abstract

4th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, will be organized around the theme “Pre-formulation, Formulation, and Physiology; Approaches for Drug Delivery Systems”

Pharmaceutica-2014 is comprised of 11 tracks and 65 sessions designed to offer comprehensive sessions that address current issues in Pharmaceutica-2014.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Preformulation considerations for solid and semi solid dosage forms
  • Track 1-2Preformulation considerations for solution and suspension formulations
  • Track 1-3Preformulation considerations for freeze dried and parenteral formulations
  • Track 1-4Preformulation considerations for inhalational dosage forms
  • Track 1-5Stability studies and regulatory considerations
  • Track 1-6Applications of analytical techniques in preformulation studies
  • Track 2-1Advances in oral and nasal drug delivery
  • Track 2-2Developments in ophthalmic drug delivery systems
  • Track 2-3Topical drug delivery systems
  • Track 2-4Parenterals and implants in drug delivery
  • Track 2-5Rectal and vaginal drug delivery
  • Track 2-6Novel routes for insulin delivery
  • Track 3-1Sustained, controlled, and modulated drug delivery
  • Track 3-2Reservoir and osmotic drug delivery system
  • Track 3-3Polymeric and transdermal drug delivery system
  • Track 3-4Lipid & RNA drug delivery systems
  • Track 3-5Medical devices and implants for effective drug delivery
  • Track 3-6Colloidal and vesicular drug delivery
  • Track 3-7Advances in devices for manufacture and charaterization
  • Track 4-1Nanotechnology in advanced drug delivery systems
  • Track 4-2Impact of nanoscience and nanotechnology on controlled drug delivery
  • Track 4-3Nanomaterials in drug delivery systems
  • Track 4-4Expectations for future micro and nanotechnologies
  • Track 4-5Advances in nano drugs for cancer chemotherapy
  • Track 4-6Multi component nano systems, quantam dots for effective drug delivery
  • Track 4-7Recent advances in dendrimer based nanosystems
  • Track 5-1Prodrugs and site-specific drug delivery
  • Track 5-2Prodrugs in cancer chemotherapy
  • Track 5-3Prodrug approach in CNS drug delivery
  • Track 5-4Recent advances in prodrug approach
  • Track 6-1Brain targeted drug delivery
  • Track 6-2Latest trends in targeted delivery for cancer treatment
  • Track 6-3Cancer biomarkers: Current issues and future directions
  • Track 6-4In-vitro drug release characterization models
  • Track 6-5Biomarkers and Biosimilars in drug targeting and delivery
  • Track 6-6Novel delivery strategies in targeted drug delivery
  • Track 6-7Significance of biomaterials in targeted drug delivery
  • Track 7-1Problems involved and overcoming challenges in the delivery of poorly soluble drugs
  • Track 7-2Overcoming bioavailability hurdles for poorly soluble clinical candidates
  • Track 7-3Novel approaches in the delivery of poorly soluble drugs
  • Track 7-4Rationale formulation design for poorly soluble compounds
  • Track 7-5Overcoming challenges in protein drug delivery
  • Track 7-6Challenges in pediatric and geriatric drug delivery
  • Track 8-1Anatomical, biochemical and physiological considerations in design and development of novel drug delivery systems
  • Track 8-2Pharmacokinetics in drug design
  • Track 8-3Pharmacokinetic behaviors of conventional and novel dosage forms
  • Track 8-4In-silico drug discovery and development
  • Track 8-5Computational methods in ADME and toxicity studies
  • Track 8-6Pharmacokinetic parameters for drug input and drug disposition
  • Track 8-7BA/BE studies of pharmacokinetic drug interactions
  • Track 9-1Design and development of biotherapeutics
  • Track 9-2Tools for biotherapeutics generation
  • Track 9-3Dry biopharmaceuticals and applications
  • Track 9-4Biopharmaceutical drugs from natural sources
  • Track 9-5Formulation techniques for biopharmaceuticals
  • Track 10-1Development of colloidal vaccine delivery system
  • Track 10-2Needle free vaccine delivery approach
  • Track 10-3Importance of immunostimulatory adjuvants
  • Track 10-4New generation vaccines for cancer therapy
  • Track 10-5Novel trends in vaccine drug delivery
  • Track 11-1Aspects of GMP, GCP, GLP for pharmaceutical products
  • Track 11-2Regulatory challenges in nano and biotech therapeutics
  • Track 11-3Patent issues for novel dosage forms
  • Track 11-4Patenting technologies for equipments used in the novel dosage form design
  • Track 11-5Regulatory requirements for NDA and ANDA